Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Humana (HUM)

NYSE Health Care Managed Health Care S&P 500
$433.74
+21.95 (+5.33%)
Close of Nov 06, 2026 · end-of-day data
Source: Humana's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$54.38B$53.77B$56.91B$64.89B$77.16B$83.06B$92.87B$106.37B$117.76B$129.66B
Selling, general & admin$7.17B$6.57B$7.53B$7.38B$10.05B$10.12B$12.67B$13.19B$13.70B$15.45B
Operating income$1.74B$4.26B$3.10B$3.19B$4.99B$3.15B$3.80B$4.01B$2.56B$2.70B
Interest expense$189.00M$242.00M$218.00M$242.00M$283.00M$326.00M$401.00M$493.00M$660.00M$631.00M
Pre-tax income$1.55B$4.02B$2.07B$3.47B$4.67B$3.42B$3.56B$3.33B$1.62B$1.44B
Income tax$938.00M$1.57B$391.00M$763.00M$1.31B$485.00M$762.00M$836.00M$413.00M$250.00M
Net income$614.00M$2.45B$1.68B$2.71B$3.37B$2.93B$2.81B$2.49B$1.21B$1.19B
EBITDA$2.13B$4.67B$3.54B$3.70B$5.51B$3.74B$4.51B$4.79B$3.40B$3.40B
EPS (basic)$4.11$16.94$12.24$20.20$25.47$22.79$22.20$20.09$10.01$9.87
EPS (diluted)$4.07$16.81$12.16$20.10$25.31$22.67$22.08$20.00$9.98$9.84
Diluted shares150.92M145.59M138.40M134.73M133.01M129.40M127.09M124.44M120.87M120.83M
Operating margin3.2%7.9%5.4%4.9%6.5%3.8%4.1%3.8%2.2%2.1%
Net margin1.1%4.6%3.0%4.2%4.4%3.5%3.0%2.3%1.0%0.9%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$3.88B$4.04B$2.34B$4.05B$4.67B$3.39B$5.06B$4.69B$2.22B$4.20B
Short-term investments$7.59B$9.56B$10.03B$10.97B$12.55B$13.19B$13.88B$16.63B$18.21B$15.70B
Receivables$1.28B$854.00M$1.01B$1.06B$1.14B$1.81B$1.67B$2.04B$2.70B$3.27B
Total current assets$16.19B$17.40B$16.95B$19.89B$23.64B$24.89B$26.18B$29.99B$29.82B$32.73B
Goodwill$3.27B$3.28B$3.90B$3.93B$4.45B$11.09B$9.14B$9.55B$9.63B$9.69B
Total assets$25.40B$27.18B$25.41B$29.07B$34.97B$44.36B$43.05B$47.06B$46.48B$48.91B
Total current liabilities$7.82B$9.41B$10.08B$10.93B$13.39B$15.33B$17.18B$18.87B$16.94B$16.35B
Short-term debt$300.00M$150.00M$1.69B$699.00M$600.00M$1.95B$2.09B$1.44B$577.00M$0
Long-term debt$3.79B$4.77B$4.38B$4.97B$6.06B$10.54B$9.03B$10.21B$11.14B$12.37B
Total debt$4.09B$4.92B$6.07B$5.67B$6.66B$12.49B$11.13B$11.66B$11.72B$12.37B
Total liabilities$14.71B$17.34B$15.25B$17.04B$21.24B$28.25B$27.68B$30.75B$30.03B$31.17B
Shareholders' equity$10.69B$9.84B$10.16B$12.04B$13.73B$16.08B$15.31B$16.26B$16.38B$17.66B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.94B$4.05B$2.17B$5.28B$5.64B$2.26B$4.59B$3.98B$2.97B$921.00M
Capital expenditures$527.00M$524.00M$612.00M$736.00M$964.00M$1.34B$1.14B$1.00B$575.00M$546.00M
Free cash flow$1.41B$3.53B$1.56B$4.55B$4.67B$920.00M$3.45B$2.98B$2.39B$375.00M
Investing cash flow-$1.36B-$2.94B-$3.09B-$1.28B-$3.06B-$6.56B-$1.01B-$3.49B-$2.95B$2.27B
Financing cash flow$732.00M-$945.00M-$785.00M-$2.29B-$1.96B$3.02B-$1.91B-$856.00M-$2.49B-$1.22B
Dividends paid$177.00M$220.00M$265.00M$291.00M$323.00M$354.00M$392.00M$431.00M$431.00M$430.00M
Share buybacks$104.00M$3.37B$1.09B$1.07B$1.82B$79.00M$2.10B$1.57B$817.00M$151.00M
Stock-based compensation$115.00M$157.00M$137.00M$163.00M$181.00M$180.00M$216.00M$175.00M$207.00M$241.00M
Depreciation & amortization$388.00M$410.00M$444.00M$505.00M$528.00M$596.00M$709.00M$779.00M$839.00M$698.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.